Don’t miss a thing! Sign up to get the latest announcements, important dates, and news.

News & Updates

The VEINS 2020 Preview

November 14, 2020

Raghu Kolluri, MS, MD VIVA Board of Directors | The VEINS Course Director For 10 years, The VEINS has met its mission of providing unparalleled venous education. Annually, the conference has expanded and adapted to reach an ever-growing audience of healthcare providers, both in numbers and the diversity of specialties ...

News & Updates

4-Year DCB Mortality Across ILLUMENATE RCTs

November 7, 2020

Presented by Sean Lyden, MD The Stellarex (Philips) drug-coated balloon (DCB) is a unique low-dose 2mcg/dl paclitaxel-coated balloon using polyethylene glycol as an excipient. The Stellarex DCB has been studied in 7 above-the-knee popliteal studies in over 2900 patients treated with independent clinical event committe ...

News & Updates

2-Year Outcomes of a Multi-Centre Study on Infrapopliteal Bioresorbable Vascular Scaffold

November 7, 2020

Presented by Steven Kum, MD Chronic Limb Threatening Ischemia (CLTI) continues to plague many patients worldwide and is associated with complex comorbidities, poor vessel patency, and major lower extremity amputations. Plain balloon angioplasty is still the mainstay of treatment although metallic drug-eluting stents h ...

News & Updates

24-Month Outcomes from the DETOUR 1 Trial for Percutaneous Femoropopliteal Bypass

November 7, 2020

Presented by Ehrin Armstrong, MD The DETOUR1 Trial was designed to evaluate the safety and effectiveness of the Detour System for percutaneous fem-pop bypass, which received FDA’s Breakthrough Device Designation. Using the novel PQ Crossing Device and a series of specially designed Torus Stent Grafts, the Detour proced ...

News & Updates

Drug-Coated Devices & Limb Outcomes After Endovascular Peripheral Artery Revascularizations: Insights from VOYAGER

November 7, 2020

Presented by Connie N. Hess, MD, MHS Endovascular lower extremity revascularization (LER) is used to treat symptomatic peripheral artery disease (PAD) but is limited by restenosis. Although paclitaxel drug-coated devices (DCD) improve patency, they have been associated with long-term mortality. Recent data from VOYAGER ...

Load More